Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

The Faces of Luminex: Carrie Prehoda, Accounting

Keeping the financial statements for any company is a critical job, but especially so for a publicly traded firm like Luminex that has to report its finances to the U.S. Securities and Exchange Commission. We trust our data to Carrie Prehoda, Manager of Accounting and Stock Plan Administration, who joined the company in 2016.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

RT @Luminex: Here, fishie fishie: In a study of zebrafish larvae, scientists at the @UW used our MAGPIX® system to identify gene expression…
h J R
RT @Luminex: "With a test like this, it's so quick. They come in, the test is done, and they go." Speed is key when keeping #flu and other…
h J R
RT @Luminex: Congratulations to our very own @Hilary_Luminex, PhD, MA, Don Chandler, PhD, and Sherry Dunbar, PhD, MBA! Their collaborative…
h J R

Latest News

February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018


xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands